CHICAGO, Oct. 29, 2019 (GLOBE NEWSWIRE) — “Tempus, a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare, today announced that Dr. Scott Gottlieb, MD, has joined its Board of Directors. Dr. Gottlieb will serve as an advisor to Tempus and its leadership team, leveraging his vast experience as a medical policy expert and public health advocate to support Tempus as it harnesses the power and promise of big data and artificial intelligence to personalize patient care.
Dr. Gottlieb most recently served as the 23rd Commissioner of the Food and Drug Administration (FDA), where he focused on developing innovative approaches to improving medical outcomes, reshaping healthcare delivery, and expanding patient choice and safety. Previously, he also served as the agency’s Deputy Commissioner for Medical and Scientific Affairs and as a Senior Advisor to the FDA Commissioner. During his time as a Senior Advisor to the Administrator of the Centers for Medicare and Medicaid Services, Dr. Gottlieb worked on the implementation of the Medicare drug benefit, where he supported policy work on quality improvement and the agency’s coverage process, particularly as it related to new medical technologies.”
Anderson Cooper brings you highlights from CNN’s premier nightly news program AC360. At least 24 people have died in the wildfires that have ravaged Los Angeles County, and…
Newt talks with Dr. Weifeng Zhong, about the significant cybersecurity breach involving the US Treasury Department, where a hacker accessed security keys to override protocols…
On January 13, 2025, the Animal and Plant Health Inspection Service (APHIS), part of the United States Department of Agriculture (USDA), announced that it has…